Minor
IMVT-1402 · Graves' Disease (GD)
Trial sites expanded: 105 → 131 locations
Immunovant Sciences GmbHPhase 2 NCT07286006 Registry history of NCT07286006 on ClinicalTrials.gov (opens the registry)
Updated
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Trial sites expanded: 105 → 131 locations
Immunovant Sciences GmbHPhase 2 NCT07286006 Registry history of NCT07286006 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 2 | 7 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07039916 | Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe… | Generalized Myasthenia Gravis | Recruiting | 2026-07-30 |
| Phase 2 | ||||
| NCT07032662 | Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy… | Chronic Inflammatory Demyelinating Polyneuropathy | Recruiting | 2026-09-30 |
| NCT06727604 | A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for… | Graves' Disease | Recruiting | 2026-08-25 |
| NCT07018323 | A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for… | Graves' Disease | Recruiting | 2026-08-25 |
| NCT07286006 | A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD) | Graves' Disease | Enrolling by Invitation | 2026-09-29 |
| NCT06979531 | Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease… | Primary Sjögren's Syndrome | Active, Not Recruiting | 2026-09-10 |
| NCT06980805 | A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants… | Subacute Cutaneous Lupus Erythematosus | Active, Not Recruiting | 2026-08-28 |
| NCT06754462 | A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult… | Rheumatoid Arthritis | Active, Not Recruiting | 2026-04-22 |
Lupus (SLE) (1) · Myasthenia Gravis (1) · Rheumatoid Arthritis (1)